eEFFECTOR Therapeutics, Inc. - EFTR Net earnings per share for the last 12 months

Public company logo of eEFFECTOR Therapeutics, Inc. (EFTR)

eFFECTOR Therapeutics (EFTR) possesses high scientific authority in developing selective inhibitors for lung cancer therapy. The annual percentage growth of EPS TTM reflects current dynamics, with the value holding at -623.40. However, the business is currently winding down operations due to a funding shortage, while global conflicts are blocking logistics and the execution of critical international clinical trials.

effector.com (EFTR): Earnings per share for the last twelve months from 02/11/2024 to 02/20/2024

eEFFECTOR Therapeutics Inc. - analytical breakdowns and key metrics (EFTR)

- share price and consensus valuation forecast:
Share Price eEFFECTOR Therapeutics|EFTR - Analyst Consensus Forecast
- issuer market value details:
Market Valuation eEFFECTOR|EFTR - Enterprise Value
- book capitalization data:
Net Asset Value per Share eEFFECTOR Therapeutics|EFTR - Company Book Value|Market Value to Book Value effector.com|EFTR - Company Total Assets
- company total debt and liquidity indicators:
Debt to Capital eFFECTOR Therapeutics|EFTR - Long-Term Debt to Capital|Current Liabilities to Equity eFFECTOR Therapeutics|EFTR - Company Aggregate Debts|Debts to Book Capitalization Ratio eEFFECTOR|EFTR - Company Long-Term Debts|Short-Term Debt eEFFECTOR Therapeutics|Quick Liquidity Indicator effector.com
- net income and valuation ratios data:
EFTR - Net Income|Future Net Profit eFFECTOR Therapeutics|EFTR - Price to Earnings Ratio|Projected Price to Earnings Ratio eEFFECTOR|EFTR - Price/Earnings to Growth Ratio|Business Value to Operating Income Before Depreciation eEFFECTOR Therapeutics|EFTR - Operating profit before deduction of amortization|Earnings per share for the trailing year eEFFECTOR Therapeutics|EFTR - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months effector.com|EFTR - Earnings growth in current year|Expected earnings per share trend next year eFFECTOR Therapeutics
- revenue and sales details:
EFTR - Revenue and Sales Volume|Company Expected Sales Volume eEFFECTOR Therapeutics, Inc.|EFTR - Price-to-Revenue Ratio|Forward Price to Sales eEFFECTOR
Fundamental company valuation:eEFFECTOR Therapeutics
Core merchandise of eEFFECTOR Therapeutics, Inc.

The specifics of the eFFECTOR Therapeutics (EFTR) operating model are reflected in the annual dynamics of the EPS TTM metric. This indicator captures the percentage change in trailing twelve-month net income per share, with calculations based on a comparison of current results against the same period last year. For a company in the stage of program liquidation and liquidity shortages, such fluctuations reflect the capital burn rate. An increase in this metric does not signify efficiency here, but merely records the pace of loss reduction.

Competitor analysis for eFFECTOR Therapeutics

AVBP (ArriVent) - Earnings per share for the last 12 months|LTRN: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months bioAffinity Technologies Inc.